SPARSH BIOTECH is firmly establishing itself as a significant player in the pharmaceutical sector, notably recognized for its cutting-edge technique of producing Amoxicilline and Amoxclav . The organization boasts state-of-the-art infrastructure and a focused team ensuring high-quality medications benefiting patients worldwide